EARLY DIAGNOSIS OF SEPSIS THROUGH SEPSIS MARKERS AND SEPSIS INDEX THROUGH FLOW CYTOMETRY TECHNOLOGY

Sima Chauhan; Jagadish Hansa

doi:10.22159/ajpcr.2017.v10i11.20640

Authors

Sima Chauhan Department of Pathology, Institute of Medical Sciences & SUM Hospital, Siksha O Anusandhan University, Bhubaneswar - 751 003,Odisha, India.
Jagadish Hansa Directorate of Medical Research, Institute of Medical Sciences & SUM Hospital, Siksha O Anusandhan University, Bhubaneswar - 751 003, Odisha, India.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i11.20640

Keywords:

Sepsis, Flow cytometry, Sepsis index

Abstract

Â

Â Objective: Sepsis is a major medical challenge, and remains a burden by showing minimal symptoms, non-specific manifestation which leads to the high-mortality rate. The major cause of high mortality rate is due to the diagnostic pitfalls. The sepsis mechanism involves immune suppression associated with multiorgan dysfunction, uncontrolled infection, and death. This study aims to use new parameters in diagnosis of sepsis particularly neutrophil CD64 (nCD64), monocyte human leukocyte antigen-DR (mHLA-DR), performed by flow cytometer.

Methods: Available diagnostic tools such as blood culture (gold standard) and other tools are time-consuming which leads to death because the treatment is not commenced promptly due to unavailability of quick and accurate diagnostic procedures. To overcome such instances, there are different specific cell surface markers which are introduced to reveal sepsis at the earliest using flow cytometry technique. The newer technique allows determination of different cellular and functional pathological components of sepsis. Using this technology, a newer treatment modality (granulocyte macrophage colony-stimulating factor) can be used to reverse sepsis associated immune suppression.

Results: The results suggested that the flow cytometric evaluation of nCD64, mHLA-DR expression assay, seems to be promising as comparison to other tools available for diagnosis.

Conclusion: The pilot data suggest that the flow assay, sepsis indexâ€ is a useful assay for diagnosing and discriminating sepsis in adult at intensive care unit settings in comparison to all the available current modalities of sepsis diagnosis. However, there are no other comparable parameters to diagnose early sepsis.

Downloads

Download data is not yet available.

References

AQ2

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29(7):1303-10.

Angus DC, Pereira CA, Silva E. Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets 2006;6(2):207-12.

Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365(9453):63-78.

Annane D, Aegerter P, Jars-Guincestre MC, Guidet B; CUB-RÃ©a Network. Current epidemiology of septic shock: The CUB-RÃ©a Network. Am J Respir Crit Care Med 2003;168(2):165-72.

Russell JA. Management of sepsis. N Engl J Med 2006;355(16):1699-713.

Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348(2):138-50.

Simms HH, Dâ€™Amico R. Lipopolysaccharide induces intracytoplasmic migration of the polymorphonuclear leukocyte CD11b/CD18 receptor. Shock 1995;3(3):196-203.

Lehr HA, Krombach F, MÃ¼nzing S, Bodlaj R, Glaubitt SI, Seiffge D, et al. In vitro effects of oxidized low density lipoprotein on CD11b/ CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 1995;146(1):218-27.

Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res 2004;56(5):796-803.

Cohen J. The immunopathogenesis of sepsis. Nature 2002;420(6917):885-91.

Hoesel LM, Gao H, Ward PA. New insights into cellular mechanisms during sepsis. Immunol Res 2006;34(2):133-41.

Meisel C. Granulocyte-macrophage colony stimulating factor to reverse sepsis-associated immunosuppression-a double blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009;180:640-8.

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003;31(4):1250-6.

Turki AK, Sulaiman SA. Eleveated blood pressure among patients with hypertension in general hospital of Penang, Malaysia: Does poor adherence matter? Int J Pharm Pharm Sci 2010;2(1):24-32.

Swarnakar K, Vagha J. Sepsis biomarkers in early onset neonatal sepsis-a review. Internet J Infect Dis 2013;11(1):1-9.

Devraj B, Kali A, Charles MV, Seetha KS. Modified biphasic media for blood culture. Asian J Pharm Clin Res 2016;9(3):42-3.

Pradhan R, Jain P, Paria A, Saha A, Sahoo J, Sen A, et al. Ratio of neutrophilic CD64 and monocytic HLA-DR: A novel parameter in diagnosis and prognostication of neonatal sepsis. Cytometry B 2015;64:1-8.

Shyam KB, Bhat KI. Apoptosis and flow cytometric studies of Bauhinia variegata bark extract. Asian J Pharm Clin Res 2014;7(1):45-7.

Hoffmann JJ. Neutrophil CD64 as a sepsis biomarker. Biochem Med (Zagreb) 2011;21(3):282-90.

Birle A, Nebe CT, Gessler P. Age-related low expression of HLA-DR molecules on monocytes of term and preterm newborns with and without signs of infection. J Perinatol 2003;23(4):294-9.

Azizia M, Lloyd J, Allen M, Klein N, Peebles D. Immune status in very preterm neonates. Pediatrics 2012;129(4):e967-74.

Venet F, Lepape A, Monneret G. Clinical review: Flow cytometry perspectives in the ICU-from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit Care 2011;15(5):231.

Barth E, Fischer G, Schneider EM, Wollmeyer J, Georgieff M, Weiss M. Differences in the expression of CD64 and mCD14 on polymorphonuclear cells and on monocytes in patients with septic shock. Cytokine 2001;14(5):299-302.

Haseena SB, Bai MM, Pallavi C, Thyagaraju K. Suppression of paracetamol toxicity by antioxidant principles of Hybanthus enneaspermus (L.) F. Muell. In mice blood and liver. Int J Pharm Pharm Sci 2011;3(4):90-4.

Motta M, Zini A, Regazzoli A, Garzoli E, Chirico G, Caimi L, et al. Diagnostic accuracy and prognostic value of the CD64 index in very low birth weight neonates as a marker of early-onset sepsis. Scand J Infect Dis 2014;46(6):433-9.

Monneret G, Lepape A, Voirin N, BohÃ© J, Venet F, Debard AL, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32(8):1175- 83.

Park SH, Park BG, Park CJ, Kim S, Kim DH, Jang S, et al. An extended leukocyte differential count (16 types of circulating leukocytes) using the cyto diff flow cytometric system can provide informations for the discrimination of sepsis severity and prediction of outcome in sepsis patients. Cytometry B Clin Cytometry 2014;86:244-56.

Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, et al. Neutrophil CD64 expression and serum IL-8: Sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36(5-6):283-90.

Song SH, Kim HK, Park MH, Cho HI. Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation. Thromb Res 2008;121(4):499-507.

Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol 2008;154(1):87-97.

Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, et al. Quantitative measurement of monocyte HLA-DR expression in the identification of early-onset neonatal infection. Biol Neonate 2006;89(2):75-81.